Overview

Evaluation of the Safety, Tolerability and Efficacy of iNexin™ for the Treatment of the Signs and Symptoms Associated With Dry Eye Disease

Status:
Recruiting

Trial end date:
2021-12-02

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the safety and tolerability of iNexin™ The secondary objective is to compare the efficacy of iNexin™ to Vehicle for the treatment of the signs and symptoms associated with dry eye disease.

Phase:

Phase 1

Details

Lead Sponsor:

FirstString Research, Inc.

Collaborator:

United States Department of Defense

Treatments:

Ophthalmic Solutions